Insights

Small yet focused A lean operation with 0-1 employees suggests a startup or early-stage venture open to partnerships, outsourcing, or channel partnerships to accelerate R&D, regulatory navigation, and commercial scale.

Veterinary market focus Specialization in canine orthopedic and chronic diseases positions the company for B2B collaborations with veterinary clinics, animal healthcare distributors, and pet insurer programs seeking advanced cell-based therapies.

Moderate funding, early revenue With 16M in funding and revenue under 1M, there may be opportunities for grant programs, strategic co-development deals, or milestone-based partnerships with larger biotech players seeking early-stage innovation in pet therapeutics.

Awards as validation A San Diego Biotechnology award can be leveraged in outreach to potential partners, investors, and strategic customers to establish credibility and shorten diligence timelines.

Operational readiness Outpatient-ready stem cell therapies imply a value proposition for clinics and veterinary networks seeking minimally invasive, scalable treatments, suggesting sales opportunities around training, logistics, and service-model integration.

Similar companies to Animal Cell Therapies

Animal Cell Therapies Tech Stack

Animal Cell Therapies uses 8 technology products and services including Gravatar, Cloudflare, RSS, and more. Explore Animal Cell Therapies's tech stack below.

  • Gravatar
    Audio, Video, Graphics
  • Cloudflare
    Content Management System
  • RSS
    Content Management System
  • Content Management System
  • Cloudflare DNS
    Domain Name Services
  • Twemoji
    Font Scripts
  • reCAPTCHA
    Security
  • LiteSpeed
    Web Servers

Animal Cell Therapies's Email Address Formats

Animal Cell Therapies uses at least 2 email formats:
Animal Cell Therapies Email FormatsExamplePercentage
First.Last@actcells.comJohn.Doe@actcells.com
60%
First@actcells.comJohn@actcells.com
40%

Frequently Asked Questions

What is Animal Cell Therapies's phone number?

Minus sign iconPlus sign icon
You can contact Animal Cell Therapies's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Animal Cell Therapies's official website and social media links?

Minus sign iconPlus sign icon
Animal Cell Therapies's official website is actcells.com and has social profiles on LinkedIn.

How much revenue does Animal Cell Therapies generate?

Minus sign iconPlus sign icon
As of November 2026, Animal Cell Therapies's annual revenue is estimated to be <$1M.

What is Animal Cell Therapies's SIC code and NAICS code?

Minus sign iconPlus sign icon
Animal Cell Therapies's SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Animal Cell Therapies have currently?

Minus sign iconPlus sign icon
As of November 2026, Animal Cell Therapies has approximately 1 employees across 1 continents, including North America. Key team members include Ceo: J. R., Owner: K. P. and Director Quality: E. K. Explore Animal Cell Therapies's employee directory with LeadIQ.

What industry does Animal Cell Therapies belong to?

Minus sign iconPlus sign icon
Animal Cell Therapies operates in the Biotechnology industry.

What technology does Animal Cell Therapies use?

Minus sign iconPlus sign icon
Animal Cell Therapies's tech stack includes Gravatar, Cloudflare, RSS, WordPress, Cloudflare DNS, Twemoji, reCAPTCHA and LiteSpeed.

What is Animal Cell Therapies's email format?

Minus sign iconPlus sign icon
Animal Cell Therapies's email format typically follows the pattern of First.Last@actcells.com. Find more Animal Cell Therapies email formats with LeadIQ.

How much funding has Animal Cell Therapies raised to date?

Minus sign iconPlus sign icon
As of November 2026, Animal Cell Therapies has raised $16M in funding. The last funding round occurred on Apr 22, 2021.
Animal Cell Therapies logo

Animal Cell Therapies

BiotechnologyCalifornia, United States0-1 Employees

Animal Cell Therapies, Inc. is a veterinary biotechnology research company focused on stem cell science for dogs, aiming to develop treatments for orthopedic and chronic diseases. Its objective is to standardize therapies to improve efficacy, ensure product consistency, and enable outpatient administration. With about 78 million dogs in the United States and orthopedic problems affecting roughly one in four dogs, the company targets improvements in pet health outcomes.
Based in San Diego, California, the firm maintains a very small staff. In 2019, it was recognized with the San Diego Award in Biotechnology by the San Diego Award Program.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
0-1

Section iconFunding & Financials

  • $16M

    Animal Cell Therapies has raised a total of $16M of funding over 6 rounds. Their latest funding round was raised on Apr 22, 2021.

  • <$1M

    Animal Cell Therapies's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.